Search

everythinglearnresearchcommunity

for

Search:↓

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Dermatological conditions are complex, and treatments have mixed results.

Hair loss may indicate higher risk of heart disease.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

Scalp dermoscopy is good for diagnosing a type of hair loss and helps choose the best spots for biopsy.

Different types of stem cells with unique roles exist in blood, skin, and intestines, and this variety is important for tissue repair.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Hair loss linked to higher heart disease risk in both men and women.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

Minoxidil improves blood flow in heart failure patients.

Using minoxidil on dogs can cause serious cardiovascular damage, including arterial injury and hemorrhagic lesions.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

K16 can partially replace K14 but causes hair loss and skin issues.

HIV can cause unusual and severe skin problems that are hard to treat.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Progesterone boosts alcohol's effect on brain, finasteride counters it.

A special hydrogel helps heal skin without scars and regrows hair.